Abbott Laboratories Share Price Buenos Aires S.E.
Stocks
ABT
ARDEUT110608
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Buenos Aires S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 44,000.00 ARS | +2.47% |
|
+2.80% | -7.91% |
| 30/10 | Perrigo to sell infant formula business to MeridianMade for up to $175 million | RE |
| 29/10 | Perrigo to sell infant formula business to MeridianMade for up to $175 million | RE |
| Market Cap | 18TCr 2,82,63300Cr 16TCr 15TCr 14TCr 26TCr 17,44900Cr 26TCr 1,80500Cr 72TCr 9,17900Cr 69TCr 67TCr 28,94600Cr | P/E 2026 * |
35.1x | P/E 2027 * | 25.6x |
|---|---|---|---|---|---|
| Enterprise Value | 21TCr 3,18,86000Cr 19TCr 17TCr 15TCr 29TCr 19,68500Cr 29TCr 2,03700Cr 82TCr 10,35500Cr 78TCr 76TCr 32,65600Cr | EV / Sales 2026 * |
4.15x | EV / Sales 2027 * | 3.81x |
| Free-Float |
86.16% | Yield 2026 * |
2.44% | Yield 2027 * | 2.6% |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| ABT | End-of-day quote | |
Buenos Aires S.E.
| ABTD | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | +2.47% | ||
| 1 week | +2.80% | ||
| Current month | +10.17% | ||
| 1 month | +10.17% | ||
| 3 months | +6.64% | ||
| 6 months | +29.49% | ||
| Current year | -7.91% |
| 1 week | 41,800 |  | 44,300 |
| 1 month | 38,660 | | 44,300 |
| Current year | 30,380 | | 49,620 |
| 1 year | 30,380 | | 51,400 |
| 3 years | 19,675 | | 53,525 |
| 5 years | 5,360.5 | | 53,525 |
| 10 years | 145 | | 53,525 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | +2.80% | - | - | 18TCr | |
| +1.56% | +2.41% | -14.82% | +14.19% | 18TCr | |
| -6.38% | -4.98% | -20.90% | +11.15% | 11TCr | |
| -0.59% | +1.18% | +6.12% | +37.97% | 12TCr | |
| +3.42% | +1.71% | -42.32% | +9.52% | 9.46TCr | |
| +0.09% | -0.05% | -3.04% | +78.44% | 6.31TCr | |
| -0.46% | +0.42% | +8.19% | +82.97% | 5.57TCr | |
| -0.23% | -0.52% | +10.31% | -21.19% | 5.39TCr | |
| -4.30% | -1.64% | -12.30% | +39.06% | 4.34TCr | |
| +0.58% | +2.00% | -1.07% | -6.43% | 3.47TCr | |
| Average | -0.38% | +0.06% | -7.76% | +27.30% | 8.44TCr | |
| Weighted average by Cap. | +0.09% | +0.23% | -10.66% | +25.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5TCr 76,84400Cr 4.47TCr 4.12TCr 3.73TCr 6.97TCr 4,74400Cr 7.1TCr 49TCr 20TCr 2,49600Cr 19TCr 18TCr 7,87000Cr | 5.35TCr 82,32600Cr 4.79TCr 4.41TCr 4TCr 7.47TCr 5,08300Cr 7.61TCr 53TCr 21TCr 2,67400Cr 20TCr 20TCr 8,43100Cr |
| Net income | 564.32Cr 8,67900Cr 505.41Cr 464.9Cr 421.23Cr 787.39Cr 54TCr 802.13Cr 5.54TCr 2.23TCr 28TCr 2.12TCr 2.07TCr 89TCr | 766.31Cr 11,78600Cr 686.3Cr 631.29Cr 572Cr 1.07TCr 73TCr 1.09TCr 7.53TCr 3.02TCr 38TCr 2.88TCr 2.81TCr 1,20700Cr |
| Net Debt | 2.36TCr 36,22700Cr 2.11TCr 1.94TCr 1.76TCr 3.29TCr 2,23700Cr 3.35TCr 23TCr 9.29TCr 1,17600Cr 8.84TCr 8.65TCr 3,71000Cr | 2.01TCr 30,97300Cr 1.8TCr 1.66TCr 1.5TCr 2.81TCr 1,91200Cr 2.86TCr 20TCr 7.94TCr 1,00600Cr 7.56TCr 7.4TCr 3,17200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | ARS 44,000.00 | +2.47% | 1,976 |
| 29/26/29 | ARS 42,940.00 | +0.80% | 645 |
| 28/26/28 | ARS 42,600.00 | +0.61% | 851 |
| 27/26/27 | ARS 42,340.00 | -3.55% | 1,026 |
| 26/26/26 | ARS 43,900.00 | +2.57% | 1,962 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
